2006
IAPO's Annual Financial Report and associated documents can be viewed through the links below.

IAPO Annual Financial Report 2006

Notes to Annual Financial Report 2006

IAPO Independent Examination Report 2006

Project funding and in-kind support for the Patient Advocacy Research Project, Perceptions of Healthcare, was received from Pfizer Inc.

Funding or in-kind support for IAPO’s Global Patients Congress in 2006 from the following, companies, associations, patients’ organizations and individuals:

Pfizer, Novartis, PhRMA, Baxter, farmaindustria, Eucomed, Amgen, Guidant, Medtronic, Merck, IFPMA, Actelion, Aspreva Pharmaceuticals, AdvaMed, Serono, American Diabetes Association, American Autoimmune-Related Diseases Association Inc, Health Consumer Powerhouse, National Health Council, Kidney Cancer Association, Cancer Research and Prevention Foundation, Syncope Trust and Reflex Anoxic Seizures, Community Health and Information Network (CHAIN), Arrhythmia Alliance, GlaxoSmithKline, Spanish Coalition of Citizens with Chronic Illness, The Catalan Rheumatology League, Daniele Letore and Christine Marking.

An unrestricted educational grant was received for IAPO’s Workshop on Biosimilar Medicines (held December 2006) from Janssen Cilag (a Johnson & Johnson company) and from Amgen to launch the paper at the European Parliament.

Support from the World Health Organization to enable IAPO’s participation in the WHO IMPACT Meetings and WHO World Alliance for Patient Safety, Patients for Patient Safety meetings and events.

IAPO has also received expenses and sometimes honorarium to attend and/or present at a number of conferences and meetings.

Archive financial information can be found here.